Global Methotrexate Market Insights, Forecast to 2030

Publication ID:

PB507247464

Publication Date:

July 9, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
The global Methotrexate market is projected to grow from US$ 532.4 million in 2024 to US$ 624.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.7% during the forecast period.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
Report Covers:
This report presents an overview of global market for Methotrexate, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Methotrexate, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Methotrexate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Methotrexate sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Methotrexate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Methotrexate sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Segment by Type
Methotrexate for Injection
Methotrexate Tablets
Segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Methotrexate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Methotrexate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Methotrexate sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Methotrexate Product Introduction
1.2 Market by Type
1.2.1 Global Methotrexate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Methotrexate for Injection
1.2.3 Methotrexate Tablets
1.3 Market by Application
1.3.1 Global Methotrexate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Used for Cancers
1.3.3 Used for Rheumatoid Arthritis
1.3.4 Used for Other Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Methotrexate Sales Estimates and Forecasts 2019-2030
2.2 Global Methotrexate Revenue by Region
2.2.1 Global Methotrexate Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Methotrexate Revenue by Region (2019-2024)
2.2.3 Global Methotrexate Revenue by Region (2025-2030)
2.2.4 Global Methotrexate Revenue Market Share by Region (2019-2030)
2.3 Global Methotrexate Sales Estimates and Forecasts 2019-2030
2.4 Global Methotrexate Sales by Region
2.4.1 Global Methotrexate Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Methotrexate Sales by Region (2019-2024)
2.4.3 Global Methotrexate Sales by Region (2025-2030)
2.4.4 Global Methotrexate Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Methotrexate Sales by Manufacturers
3.1.1 Global Methotrexate Sales by Manufacturers (2019-2024)
3.1.2 Global Methotrexate Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Methotrexate in 2023
3.2 Global Methotrexate Revenue by Manufacturers
3.2.1 Global Methotrexate Revenue by Manufacturers (2019-2024)
3.2.2 Global Methotrexate Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Methotrexate Revenue in 2023
3.3 Global Key Players of Methotrexate, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Methotrexate Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Methotrexate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Methotrexate, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Methotrexate, Product Offered and Application
3.8 Global Key Manufacturers of Methotrexate, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Methotrexate Sales by Type
4.1.1 Global Methotrexate Historical Sales by Type (2019-2024)
4.1.2 Global Methotrexate Forecasted Sales by Type (2025-2030)
4.1.3 Global Methotrexate Sales Market Share by Type (2019-2030)
4.2 Global Methotrexate Revenue by Type
4.2.1 Global Methotrexate Historical Revenue by Type (2019-2024)
4.2.2 Global Methotrexate Forecasted Revenue by Type (2025-2030)
4.2.3 Global Methotrexate Revenue Market Share by Type (2019-2030)
4.3 Global Methotrexate Price by Type
4.3.1 Global Methotrexate Price by Type (2019-2024)
4.3.2 Global Methotrexate Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Methotrexate Sales by Application
5.1.1 Global Methotrexate Historical Sales by Application (2019-2024)
5.1.2 Global Methotrexate Forecasted Sales by Application (2025-2030)
5.1.3 Global Methotrexate Sales Market Share by Application (2019-2030)
5.2 Global Methotrexate Revenue by Application
5.2.1 Global Methotrexate Historical Revenue by Application (2019-2024)
5.2.2 Global Methotrexate Forecasted Revenue by Application (2025-2030)
5.2.3 Global Methotrexate Revenue Market Share by Application (2019-2030)
5.3 Global Methotrexate Price by Application
5.3.1 Global Methotrexate Price by Application (2019-2024)
5.3.2 Global Methotrexate Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Methotrexate Market Size by Type
6.1.1 US & Canada Methotrexate Sales by Type (2019-2030)
6.1.2 US & Canada Methotrexate Revenue by Type (2019-2030)
6.2 US & Canada Methotrexate Market Size by Application
6.2.1 US & Canada Methotrexate Sales by Application (2019-2030)
6.2.2 US & Canada Methotrexate Revenue by Application (2019-2030)
6.3 US & Canada Methotrexate Market Size by Country
6.3.1 US & Canada Methotrexate Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Methotrexate Sales by Country (2019-2030)
6.3.3 US & Canada Methotrexate Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Methotrexate Market Size by Type
7.1.1 Europe Methotrexate Sales by Type (2019-2030)
7.1.2 Europe Methotrexate Revenue by Type (2019-2030)
7.2 Europe Methotrexate Market Size by Application
7.2.1 Europe Methotrexate Sales by Application (2019-2030)
7.2.2 Europe Methotrexate Revenue by Application (2019-2030)
7.3 Europe Methotrexate Market Size by Country
7.3.1 Europe Methotrexate Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Methotrexate Sales by Country (2019-2030)
7.3.3 Europe Methotrexate Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Methotrexate Market Size
8.1.1 China Methotrexate Sales (2019-2030)
8.1.2 China Methotrexate Revenue (2019-2030)
8.2 China Methotrexate Market Size by Application
8.2.1 China Methotrexate Sales by Application (2019-2030)
8.2.2 China Methotrexate Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Methotrexate Market Size by Type
9.1.1 Asia Methotrexate Sales by Type (2019-2030)
9.1.2 Asia Methotrexate Revenue by Type (2019-2030)
9.2 Asia Methotrexate Market Size by Application
9.2.1 Asia Methotrexate Sales by Application (2019-2030)
9.2.2 Asia Methotrexate Revenue by Application (2019-2030)
9.3 Asia Methotrexate Sales by Region
9.3.1 Asia Methotrexate Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Methotrexate Revenue by Region (2019-2030)
9.3.3 Asia Methotrexate Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Methotrexate Market Size by Type
10.1.1 Middle East, Africa and Latin America Methotrexate Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Methotrexate Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Methotrexate Market Size by Application
10.2.1 Middle East, Africa and Latin America Methotrexate Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Methotrexate Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Methotrexate Sales by Country
10.3.1 Middle East, Africa and Latin America Methotrexate Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Methotrexate Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Methotrexate Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Teva Pharmaceutical Industries
11.1.1 Teva Pharmaceutical Industries Company Information
11.1.2 Teva Pharmaceutical Industries Overview
11.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Teva Pharmaceutical Industries Methotrexate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Pharmaceutical Industries Recent Developments
11.2 Qualitestrx (DAVA Pharmaceuticals)
11.2.1 Qualitestrx (DAVA Pharmaceuticals) Company Information
11.2.2 Qualitestrx (DAVA Pharmaceuticals) Overview
11.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Developments
11.3 Pfizer (Hospira)
11.3.1 Pfizer (Hospira) Company Information
11.3.2 Pfizer (Hospira) Overview
11.3.3 Pfizer (Hospira) Methotrexate Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Pfizer (Hospira) Methotrexate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer (Hospira) Recent Developments
11.4 Roxane Laboratories
11.4.1 Roxane Laboratories Company Information
11.4.2 Roxane Laboratories Overview
11.4.3 Roxane Laboratories Methotrexate Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Roxane Laboratories Methotrexate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roxane Laboratories Recent Developments
11.5 Sine
11.5.1 Sine Company Information
11.5.2 Sine Overview
11.5.3 Sine Methotrexate Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sine Methotrexate Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sine Recent Developments
11.6 Maoxiang
11.6.1 Maoxiang Company Information
11.6.2 Maoxiang Overview
11.6.3 Maoxiang Methotrexate Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Maoxiang Methotrexate Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Maoxiang Recent Developments
11.7 LingNan Pharmaceutical
11.7.1 LingNan Pharmaceutical Company Information
11.7.2 LingNan Pharmaceutical Overview
11.7.3 LingNan Pharmaceutical Methotrexate Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 LingNan Pharmaceutical Methotrexate Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 LingNan Pharmaceutical Recent Developments
11.8 Powerdone
11.8.1 Powerdone Company Information
11.8.2 Powerdone Overview
11.8.3 Powerdone Methotrexate Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Powerdone Methotrexate Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Powerdone Recent Developments
11.9 Huiyu
11.9.1 Huiyu Company Information
11.9.2 Huiyu Overview
11.9.3 Huiyu Methotrexate Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Huiyu Methotrexate Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Huiyu Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Methotrexate Industry Chain Analysis
12.2 Methotrexate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Methotrexate Production Mode & Process
12.4 Methotrexate Sales and Marketing
12.4.1 Methotrexate Sales Channels
12.4.2 Methotrexate Distributors
12.5 Methotrexate Customers
13 Market Dynamics
13.1 Methotrexate Industry Trends
13.2 Methotrexate Market Drivers
13.3 Methotrexate Market Challenges
13.4 Methotrexate Market Restraints
14 Key Findings in The Global Methotrexate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Companies Mentioned:

Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂